why choose us

First received: January 16, 2023

Clinical Trial: A Study to Test Experimental Blood Stage Malaria Vaccine in Burkina Faso.

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Malaria,Falciparum

Study Type: INTERVENTIONAL


Official Title: A Phase IIb Randomised Controlled Trial of the Safety, Immunogenicity and Efficacy of the Blood-stage Malaria Vaccine Candidates RH5.1 in Matrix-MTM and RH5.2-VLP in Matrix-MTM in Infants Aged 5-17 Mo

Brief Summary: This is a Phase IIb randomised controlled trial of the safety, immunogenicity and efficacy of the blood-stage malaria vaccine candidates RH5.1 in Matrix-MTM and RH5.2-VLP in Matrix-MTM in infants aged 5-17 months in Burkina Faso

Read more